Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002736 (
amyotrophic lateral sclerosis
)
19,048
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Axon degeneration and disruption of neuromuscular junctions (NMJs) are key events in
amyotrophic lateral sclerosis
(
ALS
) pathology. Although the disease's etiology is not fully understood, it is thought to involve a non-cell-autonomous mechanism and alterations in RNA metabolism. Here, we identified reduced levels of miR126-5p in presymptomatic
ALS
male mice models, and an increase in its targets: axon destabilizing Type 3 Semaphorins and their coreceptor Neuropilins. Using compartmentalized
in vitro
cocultures, we demonstrated that myocytes expressing diverse
ALS
-causing mutations promote axon degeneration and NMJ dysfunction, which were inhibited by applying Neuropilin1 blocking antibody. Finally, overexpressing miR126-5p is sufficient to transiently rescue axon degeneration and NMJ disruption both
in vitro
and
in vivo
Thus, we demonstrate a novel mechanism underlying
ALS
pathology, in which alterations in miR126-5p facilitate a non-cell-autonomous mechanism of motor neuron degeneration in
ALS
.
SIGNIFICANCE STATEMENT
Despite some progress, currently no effective treatment is available for
amyotrophic lateral sclerosis
(
ALS
). We suggest a novel regulatory role for miR126-5p in
ALS
and demonstrate, for the first time, a mechanism by which alterations in miR126-5p contribute to axon degeneration and NMJ disruption observed in
ALS
. We show that miR126-5p is altered in
ALS
models and that it can modulate Sema3 and
NRP protein
expression. Furthermore, NRP1 elevations in motor neurons and muscle secretion of Sema3A contribute to axon degeneration and NMJ disruption in
ALS
. Finally, overexpressing miR126-5p is sufficient to transiently rescue NMJ disruption and axon degeneration both
in vitro
and
in vivo
.
...
PMID:miR126-5p Downregulation Facilitates Axon Degeneration and NMJ Disruption via a Non-Cell-Autonomous Mechanism in ALS. 2977 56